Prenatal Diagnosis · 1994 · 51 citations · 23 references
MedicineMaternal HealthObstetricsMaternal Health PolicyReproductive HealthWomen's HealthAbortion CareAbortion LawPregnancyPrenatal CareAbortion Access BarriersAbortion Access InequalityAccess To AbortionAdvanced AgePregnancy Care AccessPrenatal Chromosomal DiagnosisSocial Insurance Coverage
More than 10 years after a chromosomal anomaly screening programme was set up in France for pregnant women of advanced age, amniocentesis is still a controversial issue. The reasons why eligible women did not utilize the test and whether or not the existence of social welfare coverage determined women's access to prenatal diagnosis were studied. A group of 291 women aged > or = 35 years who recently gave birth to normal liveborns was interviewed by telephone. Among those aged 38 years and over, who automatically qualified for social security coverage, 75 per cent had undergone amniocentesis as opposed to 23 per cent in the 35 to 37-year-old non-covered age group who did not qualify for social security coverage. In both groups, access to amniocentesis was found to depend on the physicians', women's and male partners' attitudes towards prenatal diagnosis and abortion. Among the younger group, the uptake depended mainly on socio-economic factors. Institutional policies should ensure greater equality of access while allowing for individual preferences.
23
Ultrasonographically detectable markers of fetal chromosomal abnormalities
K. H. Nicolaides, R. J. M. Snijders, S. Campbell et al. · The Lancet · 1992 · 388 citations
Medicine, Genetics, Obstetrics +14